Vaxart Announces Adjournment of Special Meeting of Stockholders
Meeting adjourned to September 19, 2025 at 8:30 a.m. Pacific Time Adjournment provides stockholders with more time given changes in Board composition, additional...
Vaccine
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
There are currently no approved vaccines or treatments for norovirus infectionCocrystal’s CDI-988 is the first antiviral for the potential prevention...
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
Phase 3 trial to evaluate two subcutaneous BRIUMVI dosing regimensNEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc....
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA...
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HUNTSVILLE, AL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing...
Clinical Research in LATAM: From a Standalone Site to a Regional Network, Upcoming Webinar Hosted by Xtalks
This free webinar teaches you how to scale a clinical research site into a regional network without sacrificing quality or...
Xtalks Announces its Life Science Webinar Calendar for September 2025
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, biotech, cell and gene therapy, clinical trials, drug discovery &...
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
Empowering BioLegacy to Lead Innovation in Combating the Opioid Epidemic Through Advanced Manufacturing and ResearchVANCOUVER, British Columbia, Sept. 04, 2025...
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf...
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its...
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention...
Contract Research Organization (CRO) Services Market worth $125.95 billion in 2030 with 8.3% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Sept. 1, 2025 /PRNewswire/ -- The global Contract Research Organization Services Market, valued at US$79.10 billion in...
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to...
Webinar on Vaccine Access Policy: Navigating Change Under the Trump Administration, Hosted by Xtalks
In this free webinar, learn how the recent policy and regulatory shifts are influencing vaccine access. Attendees will examine changes...
Five Mothers Unite in First-Ever Collaboration to Fund $1.5 Million Groundbreaking Ewing Sarcoma Grant
Los Angeles, California--(Newsfile Corp. - August 28, 2025) - In a powerful act of unity and determination, five mothers—each having...
IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and...
XtalPi Holdings Announces 2025 Interim Results
SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ -- Key Highlights from the Financial Report: Revenue surged 404% year over year to...
Analytical Platform for Rapid, Reliable mRNA Modality Analytics, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into rapid, reliable analytics for evolving mRNA modalities. Attendees will learn about mRNA modality-specific CQA...
Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows
Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly Development project focused on a...